NasdaqCM - Nasdaq Real Time Price • USD
Pulse Biosciences, Inc. (PLSE)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:19 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
700.00
1,418.00
--
Cost of Revenue
--
--
11,944.00
1,968.00
--
Gross Profit
--
--
-11,244.00
-550.00
--
Operating Expense
43,574.00
43,574.00
46,813.00
62,464.00
49,965.00
Operating Income
-43,574.00
-43,574.00
-58,057.00
-63,014.00
-49,965.00
Net Non Operating Interest Income Expense
1,364.00
1,364.00
-448.00
-646.00
114.00
Pretax Income
-42,210.00
-42,210.00
-58,505.00
-63,660.00
-49,851.00
Net Income Common Stockholders
-42,210.00
-42,210.00
-58,505.00
-63,660.00
-49,851.00
Diluted NI Available to Com Stockholders
-42,210.00
-42,210.00
-58,505.00
-63,660.00
-49,851.00
Basic EPS
-0.88
-0.88
-1.72
-2.28
-2.14
Diluted EPS
-0.88
-0.88
-1.72
-2.28
-2.14
Basic Average Shares
43,570.25
48,038.00
33,935.00
27,964.00
23,248.00
Diluted Average Shares
43,570.25
48,038.00
33,935.00
27,964.00
23,248.00
Total Operating Income as Reported
-43,574.00
-43,574.00
-58,057.00
-63,014.00
-49,965.00
Total Expenses
43,574.00
43,574.00
58,757.00
64,432.00
49,965.00
Net Income from Continuing & Discontinued Operation
-42,210.00
-42,210.00
-58,505.00
-63,660.00
-49,851.00
Normalized Income
-42,210.00
-42,210.00
-58,505.00
-63,660.00
-49,851.00
Interest Income
--
--
--
--
114.00
Net Interest Income
1,364.00
1,364.00
-448.00
-646.00
114.00
EBIT
-43,574.00
-43,574.00
-58,057.00
-63,014.00
-49,965.00
EBITDA
-42,367.00
-42,367.00
-56,702.00
-61,868.00
-48,870.00
Reconciled Cost of Revenue
--
--
11,944.00
1,968.00
--
Reconciled Depreciation
1,207.00
1,207.00
1,355.00
1,146.00
1,095.00
Net Income from Continuing Operation Net Minority Interest
-42,210.00
-42,210.00
-58,505.00
-63,660.00
-49,851.00
Normalized EBITDA
-42,367.00
-42,367.00
-56,702.00
-61,868.00
-48,870.00
12/31/2020 - 5/18/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NYXH Nyxoah S.A.
10.62
-1.30%
BLFS BioLife Solutions, Inc.
17.53
+3.97%
BIG1.DE Bio-Gate AG
0.9900
-1.00%
BIOT.ST Biotage AB (publ)
165.50
+1.47%
NXGL NEXGEL, Inc.
2.2100
-5.15%
KRMD KORU Medical Systems, Inc.
2.1900
0.00%
ALIF-B.ST AddLife AB (publ)
98.65
+2.02%
BONEX.ST Bonesupport Holding AB (publ)
232.00
-2.36%
ALC.SW Alcon Inc.
72.00
+0.61%
CTEC.L ConvaTec Group PLC
257.80
-6.46%